top of page

Bariatric News_AMBU_advert2.jpg

Leaderboard-Ad-(S)---Bariatric-Solutions_v4.gif

Browse by category

Search

Altimmune begins MOMENTUM obesity trial for Pemvidutide

Altimmune begins MOMENTUM obesity trial for Pemvidutide

Altimmune has enrolled the first subject in the 48-week Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide in...

Post-bariatric surgery exercise modulates brain regions associated with regulation of food intake

4 days ago

Novel compound prevents weight gain and adverse liver changes

5 days ago

Waist-to-height ratio is a better indicator of outcomes in patients with heart failure than BMI

5 days ago

bottom of page